Search Results
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
August, 2024
August 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jul
asco
Jun 27, 2024, 14:23 |
Dialogues
Career Journey to President and CEO - OncoInfluencers
Join us for an exciting new episode of “OncoInfluencers”, hosted by Dr. Gevorg Tamamyan. In this episode, we…
Jun 27, 2024, 14:17 |
Insight
Mohit Manrao: Positive high-level results from the NIAGARA Phase 3 study with IO in MIBC
Mohit Manrao, SVP, Head of US Oncology at AstraZeneca, shared on LinkedIn: “This content is…
Jun 27, 2024, 13:27 |
Blog
Douglas Flora: MRD AI tests are proving to be invaluable tools in our decision-making process
Douglas Flora shared a post on LinkedIn: “As I’ve been working my way through the latest…
Jun 27, 2024, 12:11 |
Insight
Patrick Forde: What is an acceptable rate of crossover?
Patrick Forde, Co-Director of the Division of Upper Aerodigestive Malignancies Sidney Kimmel Comprehensive Cancer Center at…
Jun 27, 2024, 08:45 |
Blog
Some papers to read today suggested by Wafik S. El-Deiry
Wafik S. El-Deiry, Associate Dean for Oncologic Sciences at the Warren Alpert Medical School, shared…
Jun 27, 2024, 08:31 |
Societies
Arndt Vogel: Phase I study of the PKMYT1 inhibitor lunresertib in combination with FOLFIRI
Arndt Vogel shared on X: "Phase I study of the PKMYT1 inhibitor lunresertib in combination…
Jun 26, 2024, 14:40 |
Blog
Shahrin Ahmed: Providing solutions for one of the most challenging cancers
Shahrin Ahmed, Medical Specialist at the Canadian Cancer Society, shared on X: . “Multiple…
Jun 26, 2024, 14:17 |
Blog
Analysis of post-hoc of CAIRO5
Arndt Vogel shared on X: "Prognostic value of total tumor volume in CRC liver metastases.…
Jun 26, 2024, 13:29 |
OncoDaily Pulse
Introducing the Chair of the Editorial Board of the OncoDaily Medical Journal
Introducing the Chair of the Editorial Board of the OncoDaily Medical Journal We proudly announce…
Jun 26, 2024, 12:05 |
Insight
Piotr Wysocki: Osimertinib after radiochemotherapy improves PFS in EGFR-mutated NSCLC patients – but is it really what they need?
Piotr Wysocki recently posted on LinkedIn: "The results of the LAURA study were presented during a…
164
165
166
167
168
All:
2889
Posts:
1651 - 1660
Matti Aapro is running for the UICC Board of Directors
CityU-AFCR Symposium on Precision Medicine and Digital Medicine
New management team at St. Anna Children's Hospital
Key Inspirational Moments with WHO Director at the Olympic Games
Remembering Susan Wojcicki, Honoring a Legacy of Leadership and Technological Innovation
Facebook
RSS Feed
Twitter
Linkedin
Youtube